低风险甲状腺癌患者的管理方法
2025年美国甲状腺协会(ATA)成人分化型甲状腺癌管理指南聚焦低至高危患者的诊疗,强调低风险患者应共享决策、对无复发者降阶治疗及长期生存照护。本文通过3例低风险分化型甲状腺癌病例展示管理选择与关键考量。
要点
- 多数分化型甲状腺癌患者为低风险疾病。
- 低风险患者管理强调共享决策与降阶治疗。
- 无复发患者需长期生存照护。
核心结论
- 2025 ATA指南强调低风险分化型甲状腺癌患者应共享决策、对无复发者降阶治疗并重视长期生存照护。
研究设计与样本
- 本文为病例展示,呈现3例低风险分化型甲状腺癌患者以说明管理选项与关键考量。
主要发现
- 多数分化型甲状腺癌患者诊断为低风险疾病。
临床怎么用
- 对低风险分化型甲状腺癌患者,临床应实践共享决策、对无复发者考虑降阶治疗并提供长期生存照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The 2025 American Thyroid Association (ATA) Management Guidelines for Adult Patients with Differentiated Thyroid Cancer focus on the care of patients with low- to high-risk disease with management recommendations reflecting the evolving evidence in the field. Most patients diagnosed with differentiated thyroid cancer have low-risk disease. For the care of patients with low-risk disease, the new clinical guidelines emphasize shared decision-making, de-escalating care in patients who are recurrence free, and long-term survivorship care. We present 3 cases of patients with diagnoses of low-risk differentiated thyroid cancer to illustrate management options and key considerations.
引用
- Pitt SC, Haymart MR. Approach to the patient with low-risk thyroid cancer. J Clin Endocrinol Metab. 2026. PMID: 42338425. doi:10.1210/clinem/dgag243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。